# Neumora Therapeutics, Inc.: Form SC 13D, filed Oct 2, 2023

- Company: [Neumora Therapeutics, Inc.](/companies/nmra.md) (CIK 1885522)
- Form: SC 13D
- Filed: 2023-10-02
- Accepted by EDGAR: Sep 29, 2023, 20:22 ET
- Period: not reported
- Accession: 0001072613-23-000508
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1885522/000107261323000508/arch-sch13d_18764.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1885522/000107261323000508/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1885522/000107261323000508/arch-sch13d_18764.htm

Filed Oct 2, 2023.
Source: SEC EDGAR, the filing index for accession 0001072613-23-000508. Last ingested by Listed: Oct 30, 2026, 16:11 ET. No prices; not investment advice.